These studies will not only present a new, safe, well-tolerated therapeutic option for patients with migraine, but also further elucidate the neurobiology of migraine. If AMPK is confirmed as a novel target for migraine treatment, drug discovery could identify more-powerful and safe activators of AMPK with improved efficacy and tolerability.